1. Bajpai, Vivek K, Swigut, Tomek, Mohammed, Jaaved, Bassik, Michael C, Wysocka, Joanna. 2023. A genome-wide genetic screen uncovers determinants of human pigmentation. In Science (New York, N.Y.), 381, eade6289. doi:10.1126/science.ade6289. https://pubmed.ncbi.nlm.nih.gov/37561850/
2. Hancock, Janelle L, Kalimutho, Murugan, Straube, Jasmin, Anderson, Robin L, Khanna, Kum Kum. 2023. COMMD3 loss drives invasive breast cancer growth by modulating copper homeostasis. In Journal of experimental & clinical cancer research : CR, 42, 90. doi:10.1186/s13046-023-02663-8. https://pubmed.ncbi.nlm.nih.gov/37072858/
3. Wang, Shiqing, Liu, Yuxin, Li, Siyu, Qin, Xuan, Yang, Shuang. . COMMD3-Mediated Endosomal Trafficking of HER2 Inhibits the Progression of Ovarian Carcinoma. In Molecular cancer research : MCR, 21, 199-213. doi:10.1158/1541-7786.MCR-22-0333. https://pubmed.ncbi.nlm.nih.gov/36445330/
4. Umbreen, Syed, Banday, Mudassir Meraj, Jamroze, Anmbreen, Konety, Badrinath R, Saleem, Mohammad. 2019. COMMD3:BMI1 Fusion and COMMD3 Protein Regulate C-MYC Transcription: Novel Therapeutic Target for Metastatic Prostate Cancer. In Molecular cancer therapeutics, 18, 2111-2123. doi:10.1158/1535-7163.MCT-19-0150. https://pubmed.ncbi.nlm.nih.gov/31467179/
5. Zhu, Tingting, Peng, Xiaolin, Cheng, Ziwei, Cheng, Wei, Zhang, Minguang. 2022. COMMD3 Expression Affects Angiogenesis through the HIF1α/VEGF/NF-κB Signaling Pathway in Hepatocellular Carcinoma In Vitro and In Vivo. In Oxidative medicine and cellular longevity, 2022, 1655502. doi:10.1155/2022/1655502. https://pubmed.ncbi.nlm.nih.gov/36092163/
6. Wang, Yajun, Zhang, Bo, Fan, Fengjuan, Sun, Chunyan, Hu, Yu. 2025. COMMD3 Regulates Copper Metabolism via the ATOX1-ATP7A-LOX Axis to Promote Multiple Myeloma Progression. In Biomedicines, 13, . doi:10.3390/biomedicines13020351. https://pubmed.ncbi.nlm.nih.gov/40002764/
智鼠故事 
